Early Access

10-QPeriod: Q1 FY2024

UNITEDHEALTH GROUP INC Quarterly Report for Q1 Ended Mar 31, 2024

Filed May 9, 2024For Securities:UNH

Summary

UnitedHealth Group Inc. reported a net loss of $1.41 billion, or $(1.53) per diluted share, for the first quarter of 2024. This loss was significantly impacted by a $7.1 billion loss on the sale of its Brazil operations and the ongoing effects of the Change Healthcare cyberattack. Despite the net loss, total revenues increased by 9% year-over-year to $99.8 billion, driven by growth across both the UnitedHealthcare and Optum segments. UnitedHealthcare saw a 7% revenue increase, serving 1.6 million more people domestically, particularly in commercial and Medicare offerings. Optum revenues grew by 13%, fueled by Optum Health and Optum Rx. The company has provided substantial financial support to care providers affected by the cyberattack, totaling $3.9 billion in accelerated funding and interest-free loans by March 31, 2024, with further impacts anticipated. While the reported net loss is substantial, investors should note that it was heavily influenced by a one-time loss from divestiture and cyberattack-related costs. The underlying revenue growth indicates continued demand for the company's diverse health services. However, the cyberattack's ramifications, including potential litigation, reputational harm, and regulatory actions, remain significant uncertainties. Management is actively managing medical cost trends and operational efficiencies, but faces pressures from Medicare Advantage rate reductions and evolving risk adjustment models. The company maintains a strong liquidity position with substantial cash and investments.

Financial Statements
Beta
Revenue$99.80B
Cost of Revenue$11.06B
Gross Profit$88.74B
SG&A Expenses$14.08B
Operating Expenses$91.86B
Operating Income$7.93B
Interest Expense$844.00M
Net Income-$1.41B
EPS (Basic)$-1.53
EPS (Diluted)$-1.53
Shares Outstanding (Basic)922.00M
Shares Outstanding (Diluted)922.00M

Key Highlights

  • 1Reported a net loss of $1.41 billion for Q1 2024, primarily due to a $7.1 billion loss on the sale of Brazil operations and cyberattack-related costs.
  • 2Total revenues grew 9% year-over-year to $99.8 billion, driven by strong performance in both UnitedHealthcare and Optum segments.
  • 3UnitedHealthcare revenues increased 7% and served 1.6 million more people domestically, with growth in commercial and Medicare offerings.
  • 4Optum segment revenues grew 13%, supported by Optum Health and Optum Rx.
  • 5The company provided approximately $3.9 billion in accelerated funding and interest-free loans to care providers affected by the Change Healthcare cyberattack through March 31, 2024.
  • 6The Change Healthcare cyberattack resulted in $593 million in direct response costs and $279 million in estimated business disruption impacts for Optum Insight during Q1 2024.
  • 7The company has identified files containing PHI or PII potentially covering a substantial portion of the US population due to the cyberattack, with ongoing investigations.

Frequently Asked Questions